» Authors » Deba Prasad Dhibar

Deba Prasad Dhibar

Explore the profile of Deba Prasad Dhibar including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 64
Citations 406
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Biswas S, Lo G, Mehta S, Elhence A, Wong Y, Vaishnav M, et al.
Dig Dis Sci . 2025 Jan; PMID: 39869165
Background: This two-stage individual patient data meta-analysis (IPD-MA) compared the efficacy of a shorter duration (≤ 2 days) of vasoactive (VA) drug therapy to standard duration (3-5 days) after acute...
2.
Selvam S, Dhibar D, Singh H, Suri V, Sharma V, Goyal K, et al.
Am J Trop Med Hyg . 2024 Dec; 112(3):674-676. PMID: 39719113
Measles or rubeola is caused by an enveloped single-stranded RNA virus belonging to the genus Morbillivirus in the Paramyxoviridae family. Here, we present five adult measles patients. The laboratory confirmation...
3.
Singh H, Dhibar D
Am J Med . 2024 Nov; 137(12):e239. PMID: 39580206
No abstract available.
4.
Kaur A, Singh H, Dhibar D
J Emerg Trauma Shock . 2024 Nov; 17(3):187-188. PMID: 39552834
No abstract available.
5.
Dharmana S, Singh H, Dhibar D, Bajaj R, Singh A, Chatterjee D, et al.
QJM . 2024 Sep; PMID: 39292562
No abstract available.
6.
Subramanian A, Rohilla M, Dhibar D, Singh H, Bandi A, Suri V, et al.
Am J Med . 2024 Aug; 137(11):e203-e204. PMID: 39094843
No abstract available.
7.
G L, Dhibar D, Saroch A, Sharma N, Sharma V, Verma N, et al.
Sci Rep . 2024 May; 14(1):11430. PMID: 38769330
Liver abscess is a potentially life-threatening medical emergency. Prompt empirical antimicrobial with or without percutaneous aspiration or drainage is therapeutic. The rational for using empirical intravenous broad-spectrum antimicrobials upfront instead...
8.
Chandrasekhar V, Singh H, Subramanian A, Dhibar D, Suri V, Bhalla A
Am J Med . 2024 Apr; 137(8):e151-e152. PMID: 38649000
No abstract available.
9.
Sood H, Pradhan N, Singh H, Dhibar D, Bethanbhatla M, Kaur H, et al.
Am J Med . 2024 Apr; 137(7):e117-e119. PMID: 38582320
No abstract available.
10.
Pannu A, Chand D, Bhalla A, Dhibar D
Toxicol Res (Camb) . 2024 Mar; 13(2):tfae023. PMID: 38450179
Introduction: Despite the widespread use of antivenom for the treatment of snakebite envenoming in the Indian subcontinent, the ideal dose of antivenom has been a point of contention. Low-dose regimens...